A new strategy to prevent the most aggressive tumors from generating resistance to chemotherapy

(Centro Nacional de Investigaciones Oncol ó gicas (CNIO)) One of the most frequent problems when treating cancer is that the tumors develop resistance to therapies. This is especially relevant in patients with aggressive diseases. A study led by the Spanish National Cancer Research Centre (CNIO) in collaboration with the Weill Cornell Medicine Center and Pfizer Inc. (United States) proposes a novel combined approach to avoid pancreatic cancer resistance to chemotherapy, and thus achieve that the treatments eliminate these tumor cells effectively.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news